Skip to main content

XARELTO

NDC 50090-3639 · A-S Medication Solutions

Generic namerivaroxaban

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)RIVAROXABAN

Strength20 mg/1

Pharmacologic classFactor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]

Marketing categoryNDA

Packages

50090-3639-0 — 90 TABLET, FILM COATED in 1 BOTTLE (50090-3639-0)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

14445-184 — Rivaroxaban, 31722-496 — RIVAROXABAN, 33342-488 — Rivaroxaban, 42571-345 — RIVAROXABAN, 43598-981 — Rivaroxaban, 46708-346 — RIVAROXABAN, 46708-347 — RIVAROXABAN, 46708-348 — RIVAROXABAN, 46708-683 — RIVAROXABAN, 50090-3625 — rivaroxaban, 50090-4468 — rivaroxaban, 50090-4469 — rivaroxaban, 50228-513 — Rivaroxaban, 50458-575 — rivaroxaban, 50458-577 — rivaroxaban, 50458-578 — rivaroxaban, 50458-579 — rivaroxaban, 50458-580 — rivaroxaban, 51672-4228 — Rivaroxaban, 55154-1422 — rivaroxaban, +23 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels